The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.
Abstract
To investigate the role of vasoconstrictor hormones in vascular smooth muscle cell growth we have studied the effects of the potent vasoconstrictor angiotensin II on cell growth in a cultured rat aortic cell model. Angiotensin II was not mitogenic for these cells, as assessed by determining cell number, nor was it synergistic in this regard with 10% calf serum. However, 24-hour exposure to 100 nM angiotensin II caused an 80% increase in protein synthesis (compared with 0.4% increase with serum control) as measured by tritiated leucine incorporation. This was a "hypertrophic" response as indicated by a 30% increase in protein content and a 45% increase in cell volume. Angiotensin II-induced smooth muscle cell hypertrophy was maximal at 100 nM, had an ED50 of 1 nM, and was inhibited by the competitive antagonist [Sar1, Ile8]angiotensin II. The increase in protein synthesis required continuous presence of angiotensin II for 6 hours and required messenger RNA (mRNA) synthesis as suggested by complete inhibition after exposure to actinomycin D. Angiotensin II-stimulated protein synthesis was dependent on a rise in intracellular Ca2+ concentration evidenced by a 70% decrease in tritiated leucine incorporation after chelation of Ca2+ with 25 microM quin 2-AM. This treatment did not alter protein synthesis induced by 10% calf serum. Decreasing extracellular Na+ to prevent Na+/H+ exchange and intracellular alkalinization did not inhibit the angiotensin II response but decreased the 10% calf serum-stimulated protein synthesis by 35%. Downregulation of protein kinase C by 24-hour treatment with phorbol 12,13-dibutyrate did not inhibit angiotensin II-induced protein synthesis, while phorbol 12-myristate 13-acetate-stimulated protein synthesis was abolished. These findings suggest that angiotensin II-induced hypertrophy, acting via a Ca2+ mechanism, may play an important role in abnormal vascular smooth muscle cell growth in certain forms of hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Early Signals in the Mitogenic Response
Rozengurt, E. (1986) · Science · doi:10.1126/science.3018928 · Cited by 1,455
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Pouysségur, J., Sardet, C., Franchi, A., L'Allemain, G., & Paris, S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4833 · Cited by 544
Griendling, K. K., Rittenhouse, S. E., Brock, T. A., Ekstein, L. S., Gimbrone, M. A., & Alexander, R. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38468-5 · Cited by 489
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms.
Raines, E. W., & Ross, R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34649-0 · Cited by 449
Angiotensin II Induces c-fos mRNA in Aortic Smooth Muscle
Taubman, M. B., Berk, B. C., Izumo, S., Tsuda, T., Alexander, R. W., & Nadal-Ginard, B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31290-5 · Cited by 396
Self-citationKaibuchi, K., Takai, Y., & Nishizuka, Y. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68938-6 · Cited by 367
Developmentally regulated production of platelet-derived growth factor-like molecules
Seifert, R. A., Schwartz, S. M., & Bowen-Pope, D. F. (1984) · Nature · doi:10.1038/311669a0 · Cited by 360
Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells
Grotendorst, G. R., Chang, T., Seppä, H. E. J., Kleinman, H. K., & Martin, G. R. (1982) · Journal of Cellular Physiology · doi:10.1002/jcp.1041130213 · Cited by 337
Cited by
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906
Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced Hypertension
Laursen, J. B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B. A., & Harrison, D. G. (1997) · Circulation · doi:10.1161/01.cir.95.3.588 · Cited by 823
Alexander, M. R., & Owens, G. K. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142315 · Cited by 773
Ushio-Fukai, M., Alexander, R. W., Akers, M., & Griendling, K. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15022 · Cited by 650
Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
Marx, S. O., Jayaraman, T., Go, L. O., & Marks, A. R. (1995) · Circulation Research · doi:10.1161/01.res.76.3.412 · Cited by 599
The restenosis paradigm revisited: An alternative proposal for cellular mechanisms
Schwartz, R. S., Holmes, D. R., & Topol, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90389-5 · Cited by 563
Ushio-Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., & Griendling, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22699 · Cited by 558
Regulation of differentiated properties and proliferation of arterial smooth muscle cells.
Thyberg, J., Hedin, U., Sjölund, M., Palmberg, L., & Bottger, B. A. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.6.966 · Cited by 553
Neuregulins Promote Survival and Growth of Cardiac Myocytes
Zhao, Y.-Y., Sawyer, D. R., Baliga, R. R., Opel, D. J., Han, X., Marchionni, M. A., & Kelly, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10261 · Cited by 504
Baas, A. S., & Berk, B. C. (1995) · Circulation Research · doi:10.1161/01.res.77.1.29 · Cited by 415
Self-citationAngiotensin II Signaling in Vascular Smooth Muscle: New Concepts
Griendling, K. K., Ushio-Fukai, M., Lassègue, B., & Alexander, R. W. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.366 · Cited by 407
Cyclophilin A Is a Secreted Growth Factor Induced by Oxidative Stress
Jin, Z.-G., Melaragno, M. G., Liao, D.-F., Yan, C., Haendeler, J., Suh, Y.-A., Lambeth, J. D., & Berk, B. C. (2000) · Circulation Research · doi:10.1161/01.res.87.9.789 · Cited by 398
Self-citationAngiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.
Griffin, S. A., Brown, W. C., MacPherson, F., McGrath, J. C., Wilson, V. G., Korsgaard, N., Mulvany, M. J., & Lever, A. F. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.626 · Cited by 391
Rao, G. N., Corson, M. A., & Berk, B. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93017-6 · Cited by 391
Self-citationSchwartzkopff, B., Motz, W., Frenzel, H., Vogt, M., Knauer, S., & Strauer, B. E. (1993) · Circulation · doi:10.1161/01.cir.88.3.993 · Cited by 385
Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms
Berk, B. C. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.999 · Cited by 383
Self-citationCELLULAR AND MOLECULAR MECHANISMS OF PULMONARY VASCULAR REMODELING
Stenmark, K. R., & Mecham, R. P. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.89 · Cited by 353
Acute and chronic regulation of aldosterone production
Hattangady, N. G., Olala, L. O., Bollag, W. B., & Rainey, W. E. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.034 · Cited by 347
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh, H., Pratt, R. E., & Dzau, V. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114893 · Cited by 326
Hatakeyama, H., Miyamori, I., Fujita, T., Takeda, Y., Takeda, R., & Yamamoto, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51084-5 · Cited by 316
Angiotensin II Signal Transduction in Vascular Smooth Muscle: Role of Tyrosine Kinases
Berk, B. C., & Corson, M. A. (1997) · Circulation Research · doi:10.1161/01.res.80.5.607 · Cited by 305
Self-citationAngiotensin actions in the kidney: Renewed insight into the old hormone
Ichikawa, I., & Harris, R. C. (1991) · Kidney International · doi:10.1038/ki.1991.249 · Cited by 284
Nickenig, G., Sachinidis, A., Michaelsen, F., Bo¨hm, M., Seewald, S., & Vetter, H. (1997) · Circulation · doi:10.1161/01.cir.95.2.473 · Cited by 260
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 255
ANG II is required for optimal overload-induced skeletal muscle hypertrophy
Gordon, S. E., Davis, B. S., Carlson, C. J., & Booth, F. W. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e150 · Cited by 132
Identification of a novel growth factor-responsive gene in vascular smooth muscle cells
Wax, S. D., Rosenfield, C. L., & Taubman, M. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99981-3 · Cited by 82
Devaux, C. A., & Camoin-Jau, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042200 · Cited by 20
Wilson, G. C., Mavros, Y., Tajouri, L., & Singh, M. F. (2019) · Journal of Aging and Physical Activity · doi:10.1123/japa.2018-0155 · Cited by 14
Inhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy
Metsärinne, K. P., Stoll, M., Falkenhahn, M., Gohlke, P., & Unger, T. (1994) · Angiotensin Receptors · doi:10.1007/978-1-4615-2464-9_13 · Cited by 6
Metadata
- Authors
- Berk, B. C., Vekshtein, V, Gordon, H. M., & Tsuda, T.
- Venue
- Hypertension
- Published
- 1989-04
- Volume
- 13
- Issue
- 4
- Pages
- 305-314
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2006739286
- Cited by
- 556
- References
- 28
- FWCI
- 26.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.